The Omega-3 Fat that Supercharges Cancer Immunity!
Physionic
Mar 26, 2026
Episode description
JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]
Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2
HEALTH AUTONOMY [COURSE]
Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy
JOIN THE COMMUNITY
Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2
EMAIL LIST
1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6
HIRE ME FOR CONSULTING:
Consulting: https://bit.ly/3dmUl2H
Created with Biorender
0:00 - Introduction
0:43 - The Story begins in the Gut
1:48 - Fat Cells, Omega-3s, and the Microbiome
5:20 - A Twist of… Weight?
8:07 - Bypass the Mechanisms: Give me Omega-3
Omega-3 on Arteries: https://www.youtube.com/watch?v=jdYETp-JbXA&t=175s
References
[Study 710] Tong T, Huang X, Li L, et al. Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy. Cell Metab. 2026;38:1-17. doi:10.1016/j.cmet.2025.12.012.
[Study 711] Tanaka I, Yano Y, Mori M, Manabe S, Fukuo K. Impact of serum eicosapentaenoic acid/arachidonic acid ratio on overall survival in lung cancer patients treated with pembrolizumab: a pilot study. Sci Rep. 2024;14:1384. doi:10.1038/s41598-024-51967-y.
Please use the following link to submit your critique: https://bit.ly/PhysionicCritique
Disclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.
Mindsip insights from this episode:
Enhance immunotherapy effects with FAD cofactor
The cofactor FAD does not combat cancer on its own but enhances the effect of a primary cancer-fighting agent like immunotherapy.
Boost cancer survival with higher omega-3 blood ratio during immunotherapy
A pilot study in humans showed that having a higher blood ratio of omega-3s correlates with improved cancer survival during immunotherapy.
Leverage microbiome to boost omega-3 DHA production
The FAD cofactor from a rich microbiome can encourage your own fat cells to convert other fats into beneficial omega-3 DHA.
Leverage microbiome-derived FAD for improved cancer immunotherapy responses
A microbiome-derived cofactor called FAD, originating from vitamin B2, is linked to better responses to cancer immunotherapy.
Consume omega-3s to enhance cancer treatment directly
You may be able to bypass the need for a specific microbiome by directly consuming omega-3 fats like DHA to enhance cancer treatment.
Understand overweight cancer paradox and treatment response
Counterintuitively, being overweight can correlate with a greater chance of responding to cancer treatment, possibly due to the microbiome producing more FAD.
Combine immunotherapy with omega-3s to enhance tumor shrinkage
The combination of immunotherapy and omega-3 fat (DHA) led to the best results in shrinking tumors in preclinical studies.
